Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 157 | 221 | 50 | 52 | 42 |
| Cost of Goods | 73 | 196 | 31 | 31 | 42 |
| Gross Profit | 84 | 25 | 19 | 21 | N/A |
| Operating Expenses | 2,496 | 2,551 | 2,466 | 3,579 | 2,937 |
| Operating Income | -2,339 | -2,330 | -2,416 | -3,527 | -2,895 |
| Other Income | 29 | -1,134 | 792 | 337 | -23 |
| Pre-tax Income | -2,310 | -3,464 | -1,624 | -3,190 | -2,918 |
| Income Tax | -14 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -2,296 | -3,484 | -1,624 | -3,190 | -2,918 |
| Net Income | $-2,296 | $-3,484 | $-1,624 | $-3,190 | $-2,918 |
| EPS Basic Total Ops | -0.10 | -0.25 | -0.09 | -0.17 | -0.16 |
| EPS Basic Continuous Ops | -0.10 | -0.18 | -0.09 | -0.17 | -0.16 |
| EPS Diluted Total Ops | -0.10 | -0.25 | -0.09 | -0.17 | -0.16 |
| EPS Diluted Continuous Ops | -0.10 | -0.18 | -0.09 | -0.17 | -0.16 |
| EBITDA(a) | $-2,330 | $-2,419 | $-2,365 | $-3,476 | $-2,845 |